The Pharma Data

MARCH 15, 2022

“Today’s approval of the first generic for one of the most commonly prescribed complex drug-device combination products to treat asthma and COPD is another step forward in our commitment to bring generic copies of complex drugs to the market, which can improve quality of life and help reduce the cost of treatment,” said Sally Choe, Ph.D.,

FDA Approval 52

FDA Approval Generic Drugs Production Drugs 52

Advarra

JULY 26, 2022

Even though CBD and cannabis usage has grown, and marketing claims have proliferated regarding potential therapeutic applications, there is still little research on their effects on the human body. Cannabis and cannabis-derived compounds are treated the same as other FDA-regulated products and subject to the same authorities and requirements.

Regulation 97

Regulation Research Production Cosmetics 97

Camargo

DECEMBER 13, 2021

Both the FDA’s Center for Drug Evaluation and Research (CDER) and its Center for Biologics Evaluation and Research (CBER) have regulatory responsibility for therapeutic biological products, which are subject to both the Federal Food, Drug and Cosmetic (FD & C) Act and the Public Health Service (PHS) Act.

Development 161

Development Production Immune Response Licensing 161

The Pharma Data

DECEMBER 13, 2020

Food and Drug Administration (FDA) approved a first-of-its-kind intentional genomic alteration (IGA) in a line of domestic pigs, referred to as GalSafe pigs, which may be used for food or human therapeutics. The FDA determined that food from GalSafe pigs is safe for the general population to eat. SILVER SPRING, Md. ,

FDA Approval 52

FDA Approval Genome Genomics Production 52

FDA Law Blog

JUNE 23, 2021

Because no data set is completely reliable in establishing a drug’s benefit, and because no drug is universally effective for all patients, there is inherent uncertainty in every drug approval. Instead, the ultimate clinical benefit must be confirmed in a post-approval study. The question is: how much uncertainty is acceptable?

FDA Approval 52

FDA Approval Drugs Development Clinical Trials 52

XTalks

MARCH 13, 2024

This led people to seek it off-label for cosmetic weight loss, a phenomenon many say is partly to blame for the current shortages of both Novo and Lilly’s GLP-1 drugs. Lilly said it doesn’t endorse use of the medications “outside of a medicine’s FDA-approved indication.”

Medicine 52

Medicine Cosmetics FDA Approval Drugs 52

Roots Analysis

JANUARY 17, 2024

Resilience of Eli Lilly in the Face of Challenges The latter half of the previous decade witnessed Eli Lilly grappling with stagnant market value and declining revenue, hovering around the USD 100 billion mark. As the drug gains momentum, the demarcation between medical and cosmetic applications becomes increasingly nuanced.

Drugs 40

Drugs Cosmetics Marketing FDA Approval 40

FDA Law Blog

APRIL 21, 2024

Usually at this point in a post we would identify the date of approval of the relevant NDA. But that’s the controversy here: Did FDA approve LYTGOBI NDA 214801 on September 30, 2022 when the Agency issued its initial approval letter , or on October 5, 2022 when FDA issued a corrected approval letter ?

Production 59

Production Marketing FDA Approval Cosmetics 59

FDA Law Blog

JANUARY 4, 2024

This unique forum, designed for in-house counsel and executives, as well as private practice attorneys working for the OTC drug industry will provide invaluable insights on FDA’s most recent directives and compliance standards governing OTC drug production, marketing and distribution.

Compliance 52

Compliance Drugs Regulation FDA Approval 52

Roots Analysis

JANUARY 3, 2024

Medical aesthetics is a growing area of modern medicine that focuses on improving the cosmetic appearance of an individual through various medical treatments. However, Botulinum toxin was the real game-changer when it was approved for cosmetic use by the FDA in 2002.

Filler 40

Filler Cosmetics Production Dermatology 40

FDA Law Blog

JANUARY 18, 2024

Rescheduling Analyses, 2016 DEA noted in 2016 that a drug had a currently accepted medical use for purposes of the CSA if it was the subject of an approved new drug application (“NDA”) under the Federal Food, Drug and Cosmetic Act. chemotherapy-induced), pain, and post-traumatic stress disorder. chemotherapy-induced), and pain.

Drugs 69

Drugs FDA Approval Containment Production 69

The Pharma Data

APRIL 7, 2023

“Fundamentally, however, the touchstone of FDA drug approval is a favorable benefit-risk assessment; without that favorable assessment, the drug should not have the status of being FDA-approved.” The agency’s approval included a requirement that the sponsor conduct a post marketing confirmatory study.

Scientist 40

Scientist FDA Approval Cosmetics Production 40

Pharmacy Checkers

NOVEMBER 21, 2019

Wikipedia has an extremely long page aptly called Criticism of the Food and Drug Administration , much of it having to do with its role with prescription drugs, and less so other sectors, such as food, tobacco and cosmetics. . There are 19,000 approved prescription drugs for marketing in the U.S. Far from it. drug supply.

Generic Drugs 68

Generic Drugs Manufacturing Drugs Regulation 68

The Pharma Data

DECEMBER 4, 2021

The launch of our first-to-market authorized generic version of Epiduo® Forte Gel in the U.S. Avoid skin products that may dry or irritate your skin such as medicated or harsh soaps, astringents, cosmetics that make your skin dry, and products containing high levels of alcohol, spices, or limes. 2.5%), in the United States.

Doctor 52

Doctor Doctors Medicine Production 52

FDA Law Blog

AUGUST 16, 2021

A PANDA, or the Pre-Hatch-Waxman Abbreviated New Drug Application, refers to abbreviated drug applications submitted and approved under sections 505(b) and 505(c) of the Federal Food, Drug, and Cosmetic Act (FDCA) prior to the enactment of the Hatch-Waxman Amendments in 1984, as FDA announced in the Federal Register last week.

Production 52

Production Drugs Generic Drugs Cosmetics 52

FDA Law Blog

SEPTEMBER 6, 2023

Food and Drug Administration – labeled an “Official Action Indicated” classification – is generally devastating for the facility, not least because it can stall FDA approval of applications to market drugs manufactured at the facility.

Generic Drugs 45

Generic Drugs Manufacturing Drugs Cosmetics 45

Intouch Solutions

JUNE 30, 2022

47% of those had made in-game purchases, and 37% had purchased virtual cosmetic items. It’s easy to imagine that expanding, though, as more apps come to market and users become more concerned about other measures of performance. The connection will be tested this summer and the companies plan a big marketing push this autumn.

Pharmacy 52

Pharmacy Radiology Cosmetics Manufacturing 52

FDA Law Blog

OCTOBER 4, 2021

Karst — In the appellate courts lately, it’s been FDA “ Against the Music.” In yet another decision based on statutory interpretation, an appellate court has decided that FDA’s interpretation of the Federal Food, Drug, and Cosmetic Act (FDCA) is contrary to the plain text of the statute. Earlier this year, the D.C.

Drugs 52

Drugs Marketing Production Cosmetics 52

FDA Law Blog

JULY 5, 2023

Palmer — Last week FDA published a long-awaited Draft Guidance for outsourcing facilities addressing the Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act (Draft Guidance). See 21 U.S.C. Section II at 2. More specifically, the prohibition includes when a “third party (e.g.,

Drugs 52

Drugs Production Manufacturing Licensing 52

FDA Law Blog

JULY 8, 2021

The former will enter the market without FDA review, while the latter will need FDA approval. These criteria are by and large different from the ones found in the language of the Federal Food, Drug, and Cosmetic Act for determining device classification. Thus, drawing the line is critically important.

Regulation 52

Regulation In-Vitro Production Genetics 52

FDA Law Blog

FEBRUARY 29, 2024

As FDA explains on its website (which includes lists— here and here —of the more than 300 Accelerated Approvals (and withdrawals)): The FDA instituted its Accelerated Approval Program to allow for earlier approval of drugs that treat serious conditions, and fill an unmet medical need based on a surrogate endpoint.

Production 59

Production Drugs FDA Approval Compliance 59

The Pharma Data

AUGUST 1, 2021

Global Botox Cosmetic net revenues were $584 million, an increase of over 100.0 The FDA cited its ongoing review of Pfizer’s post-marketing study, ORAL Surveillance, evaluating tofacitinib in patients with rheumatoid arthritis (RA). to $6.14; Raises 2021 Adjusted Diluted EPS Guidance Range from $12.37

Botox 52

Botox Cosmetics Trials Clinical Trials 52

FDA Law Blog

APRIL 30, 2021

Some of the bills introduced are related to a House Judiciary Antitrust Subcommittee hearing, titled “ Addressing Anticompetitive Conduct and Consolidation in Health Care Markets ,” while others found their way into the Bill Hopper because of a renewed interest in Congress to address drug prices (see a recent U.S. That brings us to S.

Generic Drugs 40

Generic Drugs Drugs Production Branding 40

FDA Law Blog

APRIL 30, 2021

Some of the bills introduced are related to a House Judiciary Antitrust Subcommittee hearing, titled “ Addressing Anticompetitive Conduct and Consolidation in Health Care Markets ,” while others found their way into the Bill Hopper because of a renewed interest in Congress to address drug prices (see a recent U.S. That brings us to S.

Generic Drugs 40

Generic Drugs Drugs Production Branding 40

The Pharma Data

FEBRUARY 4, 2021

– Full-Year Global Net Revenues from the Aesthetics Portfolio Were $2.590 Billion; Global Botox Cosmetic Net Revenues Were $1.112 Billion. Global Botox Cosmetic net revenues were $493 million , an increase of 9.1 – Reports Fourth-Quarter Diluted EPS of $0.01 percent on a reported basis, or 45.0 Recorded a $4.7

Botox 52

Botox Production Sales Cosmetics 52

XTalks

NOVEMBER 1, 2024

The neurology drug market continues to be dynamic with novel treatments that cater to a broad range of neurological and psychiatric conditions. In 2024, several blockbuster neurology medications are set to lead the market, capturing the attention of healthcare professionals, investors and patients alike.

FDA Approval 85

FDA Approval Drugs Botox Sales 85

XTalks

AUGUST 2, 2023

Join us as we present an in-depth analysis of each company’s revenue, net income, R&D investments, core therapeutic areas, market presence and strategic collaborations. is a global pharmaceutical company, working across both developed and emerging markets. The FDA approved the drug over a decade ago in September 2009.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

FDA Law Blog

JANUARY 4, 2023

The PIE Act, otherwise known as section 3630, “Facilitating Exchange of Product Information Prior to Approval” of H.R. FDA recommended that communications include a clear statement that the product or use is not FDA-approved and that safety or effectiveness of the product or use has not been established.

Production 64

Production Regulation FDA Approval Drugs 64

FDA Law Blog

MARCH 13, 2024

Part 2 (“Part Deux”) investigated the PTO’s position and recent decisions on PTE applications for patents covering products approved—and then withdrawn years later—under the Federal Food, Drug, and Cosmetic Act’s Accelerated Approval provisions (and otherwise). Lehman , No. 95-650-A (E.D. . 10,544,220 (the ‘220 patent).

Marketing 59

Marketing Production FDA Approval Generic Drugs 59

Pharma in Brief

JANUARY 7, 2024

On January 5, 2024, the US Food and Drug Administration ( FDA ) approved Florida’s proposal to import prescription drugs from Canada. This is the first approval of a Section 804 Importation Program ( SIP ) by the FDA. Biologics, controlled substances, and certain other drugs are not eligible for importation.

Drugs 52

Drugs Regulation FDA Approval Manufacturing 52

Pharmacy Checkers

FEBRUARY 21, 2020

On behalf of Prescription Justice, I submitted comments to the FDA in response to its request for public comments on its draft guidance called: “Importation of Certain FDA-Approved Human Prescription Drugs, Including Biological Products, under Section 801(d)(1)(B) of the Federal Food, Drug, and Cosmetic Act: Draft Guidance for Industry.”.

Drugs 61

Drugs FDA Approval Manufacturing Pharmacy 61

Pharmacy Checkers

JANUARY 30, 2020

Basically, the charge is that the Vyera took myriad actions to prevent a lower-cost generic drug from coming to market. And only if the drug is proven to be the exact same FDA-approved drug. It might but I don’t think so because only Vyera, not Glaxo, has marketing authorization to sell Daraprim in the U.S.

Drugs 54

Drugs Generic Drugs Cosmetics FDA Approval 54

FDA Law Blog

JULY 12, 2021

The Order calls on FDA “to reduce the cost of covered products to the American consumer without imposing additional risk to public health and safety, [by working] with States and Indian Tribes that propose to develop section 804 Importation Programs.” Among the Order’s mandates for DHHS are several relating to prescription drugs.

Drugs 52

Drugs Cosmetics Marketing Regulation 52

Pharmacy Checkers

AUGUST 2, 2019

Until this week, it was known that Trump had instructed Secretary Azar to work with Republican Governor Ron DeSantis of Florida to help implement its new law to permit wholesale drug importation from Canada for public payers, which also includes importation from other countries for the private market. Now, there is real movement.

Drugs 69

Drugs FDA Approval Pharmacy Cosmetics 69

Pharmacy Checkers

DECEMBER 20, 2019

The agency drafted a new proposed rule to allow importation from Canada of lower-cost drugs and industry guidance for drug manufacturers to import their FDA-approved foreign drug versions, for which they can charge lower prices. And can’t they already import FDA-approved drugs? That probably sounds confusing.

Drugs 73

Drugs FDA Approval Cosmetics Pharmacy 73